Study #2018-0703
Post Operative External Beam Radiotherapy For Prostate Cancer: Randomized Trial Comparing Standard Vs. Hypofractionated Radiation Therapy. (PORT-HYFX)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase III trial studies how well hypofractionated radiation therapy works compared to the conventional one in treating patients with prostate cancer. Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Stage I Prostate Cancer AJCC v8;Stage II Prostate Cancer AJCC v8;Stage III Prostate Cancer AJCC v8;Stage IVA Prostate Cancer AJCC v8
Study phase:
Phase III
Physician name:
Quynh-Nhu Nguyen
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.